Underutilization of guideline-recommended therapy in patients 80 years and older with peripheral artery diseases

Daniel Messiha1, Olga Petrikhovich1, Julia Lortz1

  • 1Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University of Duisburg-Essen, Germany.

Insights

Older adults with peripheral artery disease (PAD) receive less guideline-recommended treatment and specialized care. This highlights significant age-related health inequalities in managing PAD, a condition exacerbated by aging.

Area of Science:

  • Cardiovascular Medicine
  • Geriatrics
  • Health Services Research

Background:

  • Aging is a significant cardiovascular risk factor, increasing atherosclerotic burden and mortality, particularly in Peripheral Artery Disease (PAD).
  • Despite guideline-recommended treatments, their implementation in PAD care is often inadequate.
  • Age-related health inequalities in high-risk PAD populations remain under-elucidated on a national scale.

Purpose of the Study:

  • To analyze outpatient treatment structures and guideline adherence for Peripheral Artery Disease (PAD) patients over 80 years old.
  • To investigate age-related differences in the prevalence, pharmacotherapy, and specialized outpatient care of PAD patients.

Main Methods:

  • Analysis of nationwide ambulatory claims data in Germany from 2009 to 2018, covering 70.1 million individuals annually.
  • Inclusion of 17,633,970 PAD patients, with a specific focus on 28% who were over 80 years old.
  • Examination of age-related disparities in PAD prevalence, statin and antiplatelet pharmacotherapy, and access to specialized care (angiology, vascular surgery, cardiology).

Main Results:

  • PAD prevalence increased from 1.85% to 3.14% between 2008 and 2018, with the proportion of patients over 80 increasing by one-third.
  • Octogenarians were undertreated with guideline-recommended statins (46.5% vs. 52.4%) but received antiplatelets more frequently (30.6% vs. 29.3%) compared to younger patients.
  • Patients aged 80 and older had less access to specialized outpatient care, including angiology (6.4% vs. 9.5%), vascular surgery (8.1% vs. 11.8%), and cardiology (25.2% vs. 29.2%).

Conclusions:

  • Significant age-related differences exist in the pharmacotherapy and specialized outpatient care of Peripheral Artery Disease (PAD) patients.
  • Overall guideline-recommended outpatient treatment for PAD is suboptimal, with patients aged 80 and older receiving less evidence-based care.
  • Addressing these age-related health inequalities in PAD management is a critical challenge for future healthcare.

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
11
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
14
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs but also impacts other areas, such as the arms, thereby impairing overall circulation and organ function.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty deposits inside the arterial...
9
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
12
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
15